
zzso of an adequate sample size for a clinical trial has traditionally involved the zzso of type I zzso zzso and type II zzso zzso error rates, and a difference that one wishes to zzso Because newer therapy has generally been more invasive or more toxic, it is conventional for the type I error to be zzso in order that new therapy not be accepted as superior unless its advantages are definitively zzso Recently, many new trials have been directed toward showing that a more conservative treatment is equivalent in efficacy to a standard intensive zzso In this paper, we provide formulas which prescribe the sample size necessary to meet certain criteria specified by the investigator for this alternative type of clinical zzso In addition, the percent increase in total sample size is described when more patients are allocated to one treatment than the zzso 

